Pacira Biosciences Inc PCRX:NASDAQ

Last Price$57.85NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change-0.45(0.77%)
Bid (Size)$23.14 (1)
Ask (Size)$57.85 (18)
Day Low / High$56.69 - 58.40
Volume436.1 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 07/01/2022

 

Pacira Biosciences Inc ( NASDAQ )

Price: $57.85
Change: -0.45 (0.77%)
Volume: 436.1 K
4:00PM ET 7/01/2022
 
 

Corcept Therapeutics Inc ( NASDAQ )

Price: $25.44
Change: +1.66 (6.98%)
Volume: 894.3 K
4:00PM ET 7/01/2022
 
 

Insmed Inc ( NASDAQ )

Price: $20.89
Change: +1.17 (5.93%)
Volume: 632.4 K
4:00PM ET 7/01/2022
 
 

ACADIA Pharmaceuticals Inc ( NASDAQ )

Price: $14.37
Change: +0.28 (1.99%)
Volume: 1.6 M
4:00PM ET 7/01/2022
 
 

Prestige Consumer Healthcare Inc ( NYSE )

Price: $59.58
Change: +0.78 (1.33%)
Volume: 381.8 K
7:00PM ET 7/01/2022
 

Read more news Recent News

--Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors
8:41AM ET 7/01/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Needham Adjusts Price Target on Pacira BioSciences to $76 From $84, Reiterates Buy Rating
5:36AM ET 6/15/2022 MT Newswires

Pacira BioSciences (PCRX) has an average rating of outperform and price targets ranging from $54 to $94, according to analysts polled by Capital IQ. (MT...

Insider Sell: Pacira Biosciences
7:11AM ET 6/09/2022 MT Newswires

David M Stack, Director, Chief Executive Officer and Chairman, on June 06, 2022, sold 25,793 shares in Pacira Biosciences (PCRX) for $1,561,998. Following...

Insider Sell: Pacira Biosciences
7:06AM ET 6/09/2022 MT Newswires

Roy Winston, Chief Medical Officer, on June 06, 2022, sold 17,546 shares in Pacira Biosciences (PCRX) for $1,077,135. Following the Form 4 filing with the...

Company Profile

Business DescriptionPacira Biosciences, Inc. is a holding company, which provide non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam.The company was founded in December 2006 and is headquartered in Tampa, FL. View company web site for more details
Address5401 West Kennedy Boulevard
Tampa, Florida 33609
Phone+1.813.553.6680
Number of Employees518
Recent SEC Filing06/16/20224
Chairman & Chief Executive OfficerDavid M. Stack
Chief Operating OfficerDaryl J. Gaugler
Chief Financial OfficerCharles A. Reinhart
Chief Medical OfficerRoy Winston

Company Highlights

Price Open$57.90
Previous Close$58.30
52 Week Range$45.05 - 82.16
Market Capitalization$2.6 B
Shares Outstanding45.4 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/02/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings68.87
Earnings per Share$1.53
Beta vs. S&P 500N/A
Revenue$337.3 M
Net Profit Margin6.62%
Return on Equity5.40%

Analyst Ratings as of 06/29/2022

Buy
7
Overweight
1
Hold
2
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset